Cardiac Implantable Electronic Devices A Window Into the Evolution of
Cardiac Implantable Electronic Device ScienceDirect
Current clinical practice in patients with cardiac implantable
Cardiac implantable electronic devices CIEDs are used to treat a range of cardiovascular diseases and can lead to substantial clinical improvements However studies evaluating patients experiences of living with these devices are sparse and have focused mainly on implantable cardioverter defibrillators
Radiotherapy in Patients With a Cardiac Implantable Electronic Device
Pacemakers effectively treat a broad range of cardiac arrhythmias by generating an electrical impulse to reestablish regular myocardial contraction The implantation rate of pacemakers in the UK continues to increase1 The design and capability of these devices have become increasingly complex and can encompass treatment modalities for patients with heart failure by provision of cardiac
This study characterized the relationship between conduction disease and cardiac amyloidosis CA through longitudinal analysis of cardiac implantable electronic device CIED data Background Bradyarrhythmias and tachyarrhythmias are commonly reported in CA and may precede a CA diagnosis although the natural history of conduction disease in
The Information Needs and Experiences of People Living With Cardiac
Cardiac Implantable Electronic Device Sciencedirect
Cardiac implantable electronic device implantation is frequently performed with local anesthetic and moderate sedation because a deeper level of sedation is rarely needed Moreover limited retrospective data suggest that sedation instead of GA for these cases is associated with shorter procedure and recovery times reduced analgesic
Introduction Cardiac implantable electronic devices CIED implantation has become more common 1 Patients with a pacemaker PM or an implantable cardioverterdefibrillator ICD are encountered more often in todays clinical practice and the use of cardiac resynchronization therapy CRT in patients with symptomatic heart failure is on the rise 2 3
Because of substantial progress in the fields of both cardiology and oncology the prevalence of patients with cardiac electronic implantable device CIED such as pacemaker PM or implantable cardioverterdefibrillator ICD who also require radiotherapy RT for cancer is now increasing dramatically13 Globally speaking out of the 34 million new cancer cases diagnosed in European
Radiotherapy in Patients With a Cardiac Implantable Electronic Device
Update on Cardiovascular Implantable Electronic Device Infections and
Recently the Heart Rhythm Society published recommendations on management of patients with cardiac implantable electronic device CIED who require radiotherapy RT We aimed to report the experience of a teaching hospital and discuss our practice in the context of recently published guidelines
Cardiac Implantable Electronic Device Sciencedirect
The American Heart Association sponsored the first iteration of a scientific statement that addressed all aspects of cardiovascular implantable electronic device infection in 2010 Major advances in the prevention diagnosis and management of these infections have occurred since then necessitating a scientific statement update An 11member writing group was identified and included
Percent of Medicare beneficiaries who had followup visits every 12 months following cardiac implantable electronic device CIED implant by device type The 2015 to 2020 20 Medicare feeforservice claims were used to calculate the percentage of individuals with postoperative visits after CIED implant every 12 months
Cardiac implantable electronic device patient followup ScienceDirect
Most of the temporary cardiac implantable electronic devices CIEDs are implanted percutaneously however epicardial systems are now implanted in a small number of patients Novel leadless pacemaker and subcutaneous implantable cardioverter defibrillators ICDs are now available to decrease the longterm complications of transvenous systems
Cardiac Implantable Electronic Devices ScienceDirect
Perioperative management of patients with cardiac implantable